BrainPatch’s project addresses the aim of the SME Instrument by offering an innovative, safe and effective non-invasive treatment for patients with neurological disorders i.e. dementia, so that they can proactively manage their neurological health. BrainPatch’s advancement in the non-invasive brain stimulation will provide people with a wide range of safe, effective and inexpensive treatments that can be administered in specialty clinics, outpatient clinics, office-based treatment centres, etc.
The BrainPatch’s core technology improves the effectiveness of the non-invasive brain stimulation through personalisation of the stimulation in real-time. The device has the potential to provide a safe and easy method to modulate brain activity and enhance cognitive abilities for people living with dementia, but also for healthy individuals. Additionally, to support the infrastructure of the multitude of clinical and non-clinical applications developed in-house and to provide access to our technology to third parties, BrainPatch is developing a marketplace for these apps. We currently have an application for de-stressing to help restore productivity and mental capacity in a stressful environment. Potential applications can include enhancement of concentration, mood, sleep and learning as well as clinical applications in Alzheimer’s disease epilepsy, Parkinson's, ADHD, and many more.
BrainPatch is constantly engaging in a range of public speaking and exhibiting events to demonstrate the power of electrical stimulation for altering brain states and is contributing to raising public awareness of the importance of protecting our brains. When launched in the market, the global impact of non-clinical and clinical applications will be measured through the significant social and economic implications and through improving quality of life of people in need of care and of their family members.
